New Phase IIb trial of potential MS drug ATL1102......

[MSUK]

New Phase IIb trial of potential MS drug ATL1102 given go ahead

A new human clinical trial testing the drug ATL1102 to treat Multiple Sclerosis was approved by FDA, carrying the promise of new therapeutics to affected patients.

Antisense Therapeutics Limited (ANP) announced recently in a press release the FDA’s positive decision to approve their request to submit an Investigational New Drug (IND) application in the U.S. This decision allows ANP to initiate a long-term Phase IIb clinical trial for the treatment of Multiple Sclerosis (MS) with ATL1102..... Read More - http://www.ms-uk.org/ATL1102